πŸ‡ΊπŸ‡Έ FDA
Patent

US 11103514

Treatment of muscular dystrophy

granted A61KA61K31/567A61K31/569

Quick answer

US patent 11103514 (Treatment of muscular dystrophy) held by Corcept Therapeutics Incorporated expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/567, A61K31/569, A61P, A61P21/00